Characteristic | Newly diagnosed (group A) | BCR (groups B and C) | Total |
---|---|---|---|
Patients (n) | 20 | 29 | 49 |
Age | |||
Median | 68.5 | 66.0 | 67.0 |
Minimum | 49 | 43 | 43 |
Maximum | 76 | 80 | 80 |
Race (n)* | |||
White | 13 (65.0%) | 21 (72.4%) | 34 (69.4%) |
Afro-Caribbean | 7 (35.0%) | 5 (17.2%) | 12 (24.5%) |
Asian | 0 (0.0%) | 3 (10.3%) | 3 (6.1%) |
ECOG performance status (n) | |||
0 | 19 (95.0%) | 29 (100.0%) | 48 (98.0%) |
1 | 1 (5.0%) | 0 (0.0%) | 1 (2.0%) |
PSA before scan (μg/L) | 20 | 29 | 49 |
Mean | 25.2 | 1.6 | 11.2 |
SD | 27.00 | 2.32 | 20.70 |
Median | 13.8 | 0.4 | 4.2 |
Range | 5–90 | 0–10 | 0–90 |
Initial Gleason score | |||
≤3 + 4 | 1 (5.0%) | 15 (51.7%) | 16 (32.7%) |
≥4 + 3 | 19 (95.0%) | 14 (48.3%) | 33 (67.3%) |
↵* Prostate cancer aggressiveness can vary according to race.